April 25, 2024Open Access

Cordycepin enhances anti-tumor immunity in breast cancer by enhanceing ALB expression

LCLin ChenUniversity of Southern California WWWeihao WeiAnhui University of Traditional Chinese Medicine JSJin SunJiangsu Cancer Hospital

Key Points

Key points are not available for this paper at this time.

Abstract

The treatment of breast cancer still faces great challenges, and it is necessary to continuously explore effective drugs and targets to promote immune precision medicine. This study aims to investigate the immune-related regulatory mechanism of cordycepin in breast cancer.

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Chen et al. (Thu,) studied this question.

synapsesocial.com/papers/68e6d978b6db643587655a8c https://doi.org/https://doi.org/10.1016/j.heliyon.2024.e29903

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Protein Data Bank2000 · 39,988 citations
2Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin 1 1Edited by R. Huber2000 · 912 citations
3PubChem 2023 update2022 · 3,238 citations
4Visualizing and interpreting cancer genomics data via the Xena platform2020 · 4,819 citations
5The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality2012 · 720 citations

AI에게 질문

Bookmark

View Full Paper